Vestibular Paroxysmia and facial spasm may be caused by vascular compression of the vestibular and facial root entry zone. We report a case of paroxysmal nystagmus accompanied by facial spasm and which is well visualized by three-dimensional reconstruction images. The 3-dimensional reconstruction image supports the view that vestibular paroxysmia may occur with hemifacial spasm simultaneously due to vascular compression.
Hemifacial Spasm ; Spasm

No abstract available.
Hemifacial Spasm*

No abstract available.
Hemifacial Spasm*

No abstract available.
Hemifacial Spasm* ; Parotid Gland*

No abstract available.
Blinking* ; Facial Nerve* ; Hemifacial Spasm*

Thirty-nine patients with blepharospasm were treated with botulinum A toxin. Twenty-six patients had essential blepharospasm, and thirteen had hemifacial spasm. A total of 113 injections were given, and average follow-up was 14.6 months. The mean preinjection spasm intensity was 2.9+, and the mean post-injection spasm intensity was 0.7+. The mean interval between injections was 4.4 months. The treatment was effective, although transient, in all patients with essential blepharospasm and hemifacial spasm. The toxin had a prolonged effect on the patients who had previously undergone muscle stripping proced ure. The side effects were mild, transient, and local.
Blepharospasm* ; Botulinum Toxins, Type A* ; Follow-Up Studies ; Hemifacial Spasm ; Humans ; Spasm

OBJECTIVE: This study is to investigate time course of symptom disappearance in patients whose spasm relieved completely after microvascular decompression (MVD). METHODS: Of 115 patients with hemifacial spasm (HFS) who underwent MVD from April 2003 to December 2006, 89 patients who had no facial paralysis after operation and showed no spasm at last follow-up more than 1.5 years after operation were selected. Symptom disappearance with time after MVD was classified into type 1 (symptom disappearance right after operation), type 2 (delayed symptom disappearance) and type 3 (unusual symptom disappearance). Type 2 was classified into type 2a (with postoperative silent period) and type 2b (without silent period). RESULTS: Type 1, type 2a, type 2b and type 3 were 38.2%, 48.37%, 12.4% and 1.1%, respectively. Delayed disappearance group (type 2) was 60.7%. Post-operative symptom duration in all cases ranged from 0 to 900 days, average was 74.6 days and median was 14 days. In case of type 2, average post-operative symptom duration was 115.1 days and median was 42 days. Five and 3 patients required more than 1 year and 2 years, respectively, until complete disappearance of spasm. In type 2a, postoperative silent period ranged from 1 to 10 days, with an average of 2.4 days. CONCLUSION: Surgeons should be aware that delayed symptom disappearance after MVD for HFS is more common than it has been reported, silent period can be as long as 10 days and time course of symptom disappearance is various as well as unpredictable.
Facial Paralysis ; Follow-Up Studies ; Hemifacial Spasm ; Humans ; Microvascular Decompression Surgery ; Spasm

Patients with hemifacial spasm were treated with a radiofrequency stimulating assisted percutaneous radiofrequency facial nerve coagulation around the stylomastoid foramen. The initial series of 18 cases of facial spasm are described. The series included 10 men and 8 women, aged from 19 to 75 years. All patients had classical type intractable persistent hemifacial spasm. Although severe facial weakness was made after the procedure to control the heperactive dysfunction of facial nerve in all patient immediately after making lesion, all of them recovered within 6 months follow-up. The longest follow up has been 26 months and only one patient had repeated procedure who experienced recurrence of hemifacial spasm 6 months after initial procedure. The procedure is simple, easy to perform and has no definite complication except transient facial palsy.
Facial Nerve ; Facial Paralysis ; Female ; Follow-Up Studies ; Hemifacial Spasm* ; Humans ; Male ; Recurrence ; Spasm

Two hundred sixty two patients of the essential blepharospasm and hemifacial spasm were treated with Botulinum toxin A (Oculinum(R)). A total of 620 treatments was given injections over a 3-year period. A reduction in spasm intensity was noted in most patients, and the mean response time of the essential blepharospasm and hemifacial spasm were 144.2 days and 172.3 days, respectively, There was no clear relationship between age, sex, toxin dose or preinjected spasm intensity, the amount of spasm reduction, and the mean response time. The mean respone time had no difference from the first through the fourth treatments; but in hemifacial spasm, the mean response time of the second treatment was longer than that of first, third and fourth treatments. The lagophthalmos and superficial punctate keratitis were the most frequent complications. As a result of the injection to avoid the center of the upper and lower eyelids, the frequency of complications could be minimized. There was no clear difference in the beneficial effect and the mcidence of complication (lagophthalmos) between toxin stored in the vaccum and in the non-vaccum state. Patients who were treated with lidocaine mixed toxin had a less effective result than those with saline-mixed toxin.
Blepharospasm* ; Botulinum Toxins* ; Eyelids ; Hemifacial Spasm* ; Humans ; Keratitis ; Lidocaine ; Reaction Time ; Spasm

The hemifacial spasm has been proved a state of compression usually by blood vessels to the facial nerve. The vascular compression is usually obvious at operation. Since 1980 we have operated microsurgical decompression of 42 hemifacial spasm. Recently we have experienced a case in which venous running in an anterior posterior direction across the caudal aspect of the root entry zone of the facial nerve caused the spasm was coagulated and divided. After operation the patient improved and he free of facial spasm.
Blood Vessels ; Decompression* ; Facial Nerve ; Hemifacial Spasm* ; Humans ; Running ; Spasm ; Veins